Trials / Completed
CompletedNCT05296863
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia: A Randomized, Double-blind Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Dr. dr. Lili Legiawati, SpKK(K) · Academic / Other
- Sex
- Male
- Age
- 25 Years – 58 Years
- Healthy volunteers
- Accepted
Summary
This study investigated the efficacy of adipose derived stem cell conditioned media (ADSC-CM) combined with minoxidil for hair regeneration therapy in male AGA.
Detailed description
This study was a double-blind, randomized clinical trial (RCT). Two concentrations of ADSC-CM were utilized: concentrated and non-concentrated ADSC-CM. The scalp was divided vertically in half; one side was injected with 2 ml of ADSC-CM, while the control side received 2 ml of NaCl 0,9%. After the injection, patients applied topical 5% minoxidil twice daily. Clinical improvements were assessed using photographic evaluation and trichoscan every two weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil | Non-concentrated ADSC-CM is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night. |
| COMBINATION_PRODUCT | Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil | Intervention is given during week 0, 2, 4, and 6 on the left side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night. |
| COMBINATION_PRODUCT | Placebo and 5% Minoxidil | Intervention is given during week 0, 2, 4, and 6 on the right side of the scalp. Minoxidil is applied twice using a spray, in the morning and at night. |
Timeline
- Start date
- 2021-10-11
- Primary completion
- 2021-12-03
- Completion
- 2021-12-03
- First posted
- 2022-03-25
- Last updated
- 2022-03-25
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05296863. Inclusion in this directory is not an endorsement.